SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assay.

Saved in:
Bibliographic Details
Title: SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assay.
Authors: Peluso, Michael J.1 michael.peluso@ucsf.edu, Saki Takahashi1, Hakim, Jill1, Kelly, J. Daniel2, Torres, Leonel1,3, Iyer, Nikita S.3, Turcios, Keirstinne1, Janson, Owen1, Munter, Sadie E.3, Thanh, Cassandra3, Donatelli, Joanna3, Nixon, Christopher C.3, Hoh, Rebecca1, Tai, Viva1, Fehrman, Emily A.1, Hernandez, Yanel1, Spinelli, Matthew A.1, Gandhi, Monica1, Palafox, Mary-Ann4, Vallari, Ana4
Source: Science Advances. 7/28/2021, Vol. 7 Issue 31, p1-12. 12p.
Database: Academic Search Ultimate
Description
ISSN:23752548
DOI:10.1126/sciadv.abh3409